STOCK TITAN

[SCHEDULE 13G/A] Achieve Life Sciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

On 08/04/2025, Red River Bancshares (RRBI) director Teddy Ray Price disclosed insider purchases on Form 4. He bought 3,943 common shares in four open-market trades priced between $58.72 and $60.51, spending roughly $235k. Price’s direct stake increased from 370,574 to 374,074 shares; indirect holdings now total 65,381 shares via Kisatchie Industries, LLC and 6,085 shares held by his spouse. A footnote clarifies that 16,500 shares previously reported in an estate are now counted as direct ownership. No derivative securities were involved.

Although modest relative to his total position, cumulative insider buying by a board member is typically viewed as a positive sentiment signal because it aligns management with shareholders and suggests confidence in RRBI’s prospects. The filing contains no new operational or earnings data.

Il 08/04/2025, il direttore di Red River Bancshares (RRBI), Teddy Ray Price, ha comunicato acquisti di azioni da insider tramite il Modulo 4. Ha acquistato 3.943 azioni ordinarie in quattro operazioni sul mercato aperto, con prezzi compresi tra $58,72 e $60,51, spendendo circa $235.000. La partecipazione diretta di Price è aumentata da 370.574 a 374.074 azioni; le partecipazioni indirette ammontano ora a 65.381 azioni tramite Kisatchie Industries, LLC e 6.085 azioni detenute da sua moglie. Una nota chiarisce che 16.500 azioni precedentemente segnalate in un patrimonio sono ora considerate come proprietà diretta. Non sono stati coinvolti strumenti derivati.

Pur essendo modesti rispetto alla sua posizione totale, gli acquisti cumulativi da parte di un membro del consiglio sono generalmente interpretati come un segnale positivo, poiché allineano la gestione con gli azionisti e suggeriscono fiducia nelle prospettive di RRBI. La comunicazione non contiene nuovi dati operativi o sugli utili.

El 08/04/2025, el director de Red River Bancshares (RRBI), Teddy Ray Price, reveló compras de acciones internas mediante el Formulario 4. Compró 3.943 acciones ordinarias en cuatro operaciones en el mercado abierto, con precios entre $58,72 y $60,51, gastando aproximadamente $235.000. La participación directa de Price aumentó de 370.574 a 374.074 acciones; las tenencias indirectas ahora suman 65.381 acciones a través de Kisatchie Industries, LLC y 6.085 acciones en poder de su cónyuge. Una nota aclara que 16.500 acciones previamente reportadas en un patrimonio ahora se cuentan como propiedad directa. No se involucraron valores derivados.

Aunque modestas en relación con su posición total, las compras acumuladas por parte de un miembro de la junta suelen considerarse una señal positiva, ya que alinean la gestión con los accionistas y sugieren confianza en las perspectivas de RRBI. La presentación no contiene nuevos datos operativos ni de ganancias.

2025년 4월 8일, Red River Bancshares(RRBI) 이사 Teddy Ray Price가 내부자 매수 사실을 양식 4에 공개했습니다. 그는 3,943주 보통주를 4회의 공개 시장 거래를 통해 주당 $58.72에서 $60.51 사이 가격으로 약 $235,000를 지출하며 매수했습니다. Price의 직접 보유 지분은 370,574주에서 374,074주로 증가했으며, 간접 보유 지분은 Kisatchie Industries, LLC를 통해 65,381주, 배우자가 보유한 6,085주를 포함합니다. 각주에는 이전에 상속재산으로 보고된 16,500주가 이제 직접 소유로 간주된다고 명시되어 있습니다. 파생 상품은 포함되지 않았습니다.

전체 지분에 비해 소규모이지만, 이사의 누적 내부자 매수는 경영진과 주주를 일치시키고 RRBI의 전망에 대한 신뢰를 나타내는 긍정적인 신호로 일반적으로 해석됩니다. 제출 서류에는 새로운 운영 또는 수익 데이터가 포함되어 있지 않습니다.

Le 08/04/2025, le directeur de Red River Bancshares (RRBI), Teddy Ray Price, a déclaré des achats d’initiés via le formulaire 4. Il a acquis 3 943 actions ordinaires lors de quatre transactions sur le marché libre, à des prix compris entre 58,72 $ et 60,51 $, dépensant environ 235 000 $. La participation directe de Price est passée de 370 574 à 374 074 actions ; les avoirs indirects s’élèvent désormais à 65 381 actions via Kisatchie Industries, LLC et 6 085 actions détenues par son conjoint. Une note précise que 16 500 actions précédemment déclarées dans une succession sont désormais comptabilisées en propriété directe. Aucun instrument dérivé n’a été impliqué.

Bien que modeste par rapport à sa position totale, l’achat cumulatif d’initiés par un membre du conseil est généralement perçu comme un signal positif, car il aligne la direction avec les actionnaires et suggère une confiance dans les perspectives de RRBI. Le dépôt ne contient aucune nouvelle donnée opérationnelle ou sur les résultats.

Am 08.04.2025 gab der Direktor von Red River Bancshares (RRBI), Teddy Ray Price, Insider-Käufe im Formular 4 bekannt. Er erwarb 3.943 Stammaktien in vier offenen Markttransaktionen zu Preisen zwischen , wobei er etwa ausgab. Prices direkter Anteil stieg von 370.574 auf 374.074 Aktien; indirekte Beteiligungen belaufen sich nun auf 65.381 Aktien über Kisatchie Industries, LLC sowie 6.085 Aktien, die von seiner Ehefrau gehalten werden. Eine Fußnote erläutert, dass 16.500 Aktien, die zuvor als Nachlass gemeldet wurden, jetzt als direkte Eigentumsanteile zählen. Es waren keine Derivate beteiligt.

Obwohl im Verhältnis zu seiner Gesamtposition gering, wird der kumulative Insider-Kauf eines Vorstandsmitglieds üblicherweise als positives Signal gewertet, da er das Management mit den Aktionären in Einklang bringt und Vertrauen in die Aussichten von RRBI zeigt. Die Meldung enthält keine neuen operativen oder Gewinnzahlen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director buys ~$235k in RRBI stock; signals confidence, low downside risk.

The purchase adds only ~1% to Price’s already large stake but confirms continued alignment with shareholders. The weighted average price near $60 is within the stock’s recent trading band, reducing concerns of opportunistic timing. With no sales reported and no derivatives used, the filing has a clean bull bias. Market impact should be mildly positive, especially for a micro-cap bank where insider activity is closely watched.

TL;DR: Incremental buy supports holding thesis; limited size caps impact.

Insider accumulation is reassuring for long-term investors, but the 3,943-share add is immaterial to float and liquidity. The larger takeaway is transfer of 16,500 estate shares into direct ownership, improving transparency. I classify the filing as impactful on sentiment yet neutral on valuation fundamentals.

Il 08/04/2025, il direttore di Red River Bancshares (RRBI), Teddy Ray Price, ha comunicato acquisti di azioni da insider tramite il Modulo 4. Ha acquistato 3.943 azioni ordinarie in quattro operazioni sul mercato aperto, con prezzi compresi tra $58,72 e $60,51, spendendo circa $235.000. La partecipazione diretta di Price è aumentata da 370.574 a 374.074 azioni; le partecipazioni indirette ammontano ora a 65.381 azioni tramite Kisatchie Industries, LLC e 6.085 azioni detenute da sua moglie. Una nota chiarisce che 16.500 azioni precedentemente segnalate in un patrimonio sono ora considerate come proprietà diretta. Non sono stati coinvolti strumenti derivati.

Pur essendo modesti rispetto alla sua posizione totale, gli acquisti cumulativi da parte di un membro del consiglio sono generalmente interpretati come un segnale positivo, poiché allineano la gestione con gli azionisti e suggeriscono fiducia nelle prospettive di RRBI. La comunicazione non contiene nuovi dati operativi o sugli utili.

El 08/04/2025, el director de Red River Bancshares (RRBI), Teddy Ray Price, reveló compras de acciones internas mediante el Formulario 4. Compró 3.943 acciones ordinarias en cuatro operaciones en el mercado abierto, con precios entre $58,72 y $60,51, gastando aproximadamente $235.000. La participación directa de Price aumentó de 370.574 a 374.074 acciones; las tenencias indirectas ahora suman 65.381 acciones a través de Kisatchie Industries, LLC y 6.085 acciones en poder de su cónyuge. Una nota aclara que 16.500 acciones previamente reportadas en un patrimonio ahora se cuentan como propiedad directa. No se involucraron valores derivados.

Aunque modestas en relación con su posición total, las compras acumuladas por parte de un miembro de la junta suelen considerarse una señal positiva, ya que alinean la gestión con los accionistas y sugieren confianza en las perspectivas de RRBI. La presentación no contiene nuevos datos operativos ni de ganancias.

2025년 4월 8일, Red River Bancshares(RRBI) 이사 Teddy Ray Price가 내부자 매수 사실을 양식 4에 공개했습니다. 그는 3,943주 보통주를 4회의 공개 시장 거래를 통해 주당 $58.72에서 $60.51 사이 가격으로 약 $235,000를 지출하며 매수했습니다. Price의 직접 보유 지분은 370,574주에서 374,074주로 증가했으며, 간접 보유 지분은 Kisatchie Industries, LLC를 통해 65,381주, 배우자가 보유한 6,085주를 포함합니다. 각주에는 이전에 상속재산으로 보고된 16,500주가 이제 직접 소유로 간주된다고 명시되어 있습니다. 파생 상품은 포함되지 않았습니다.

전체 지분에 비해 소규모이지만, 이사의 누적 내부자 매수는 경영진과 주주를 일치시키고 RRBI의 전망에 대한 신뢰를 나타내는 긍정적인 신호로 일반적으로 해석됩니다. 제출 서류에는 새로운 운영 또는 수익 데이터가 포함되어 있지 않습니다.

Le 08/04/2025, le directeur de Red River Bancshares (RRBI), Teddy Ray Price, a déclaré des achats d’initiés via le formulaire 4. Il a acquis 3 943 actions ordinaires lors de quatre transactions sur le marché libre, à des prix compris entre 58,72 $ et 60,51 $, dépensant environ 235 000 $. La participation directe de Price est passée de 370 574 à 374 074 actions ; les avoirs indirects s’élèvent désormais à 65 381 actions via Kisatchie Industries, LLC et 6 085 actions détenues par son conjoint. Une note précise que 16 500 actions précédemment déclarées dans une succession sont désormais comptabilisées en propriété directe. Aucun instrument dérivé n’a été impliqué.

Bien que modeste par rapport à sa position totale, l’achat cumulatif d’initiés par un membre du conseil est généralement perçu comme un signal positif, car il aligne la direction avec les actionnaires et suggère une confiance dans les perspectives de RRBI. Le dépôt ne contient aucune nouvelle donnée opérationnelle ou sur les résultats.

Am 08.04.2025 gab der Direktor von Red River Bancshares (RRBI), Teddy Ray Price, Insider-Käufe im Formular 4 bekannt. Er erwarb 3.943 Stammaktien in vier offenen Markttransaktionen zu Preisen zwischen , wobei er etwa ausgab. Prices direkter Anteil stieg von 370.574 auf 374.074 Aktien; indirekte Beteiligungen belaufen sich nun auf 65.381 Aktien über Kisatchie Industries, LLC sowie 6.085 Aktien, die von seiner Ehefrau gehalten werden. Eine Fußnote erläutert, dass 16.500 Aktien, die zuvor als Nachlass gemeldet wurden, jetzt als direkte Eigentumsanteile zählen. Es waren keine Derivate beteiligt.

Obwohl im Verhältnis zu seiner Gesamtposition gering, wird der kumulative Insider-Kauf eines Vorstandsmitglieds üblicherweise als positives Signal gewertet, da er das Management mit den Aktionären in Einklang bringt und Vertrauen in die Aussichten von RRBI zeigt. Die Meldung enthält keine neuen operativen oder Gewinnzahlen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: Includes 4,181,025 shares of Common Stock issuable on the exercise of warrants.


SCHEDULE 13G



Franklin Resources, Inc.
Signature:/s/Thomas C. Mandia
Name/Title:Thomas C. Mandia, Assistant Secretary of Franklin Resources, Inc.
Date:08/01/2025
Charles B. Johnson
Signature:/s/Thomas C. Mandia
Name/Title:Attorney in Fact for Charles B. Johnson pursuant to Power of Attorney
Date:08/01/2025
Rupert H. Johnson, Jr.
Signature:/s/Thomas C. Mandia
Name/Title:Attorney in Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney
Date:08/01/2025
Franklin Advisers, Inc.
Signature:/s/Thomas C. Mandia
Name/Title:Thomas C. Mandia, Assistant Secretary of Franklin Advisers, Inc.
Date:08/01/2025

Comments accompanying signature: LIMITED POWERS OF ATTORNEY FOR SECTION 13 AND 16 REPORTING OBLIGATIONS (incorporated by reference to Schedule 13G/A No. 1 filed on October 31, 2024) LIMITED POWER OF ATTORNEY FOR SECTION 13 REPORTING OBLIGATIONS Know all by these presents, that we Franklin Templeton Investment Funds (the "Issuer"), an entity organized and existing in the Grand Duchy of Luxembourg and having our registered office at 8A rue Albert Borschette, L-1246 Luxembourg, in the person of Gregory Johnson and Vijay Advani, Directors of the Issuer, hereby makes, constitutes and appoints each of Lori Weber and Kimberly Novotny, each acting individually as the undersigned's true and lawful attorney-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to: (1)prepare, execute, acknowledge, deliver and file Schedules 13D and 13G (including any amendments thereto or any related documentation) with the United States Securities and Exchange Commission, any national securities exchanges and Franklin Resources, Inc., a Delaware corporation (the "Reporting Entity"), as considered necessary or advisable under Section 13 of the Securities Exchange Act of 1934 and the rules and regulationspromulgated thereunder, as amended from time to time (the "Exchange Act"); and (2)perform any and all other acts which in the discretion of such attorney in fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing.The undersigned acknowledges that: (1) this Limited Power of Attorney authorizes, but does not require, each such attorney in fact to act in their discretion on information provided to such attorney in fact without independent verification of such information; (2) any documents prepared and/or executed by either such attorney in fact on behalf of the undersigned pursuant to this Limited Power of Attorney will be in such form and will contain such information and disclosure as such attorney in fact, in his or her discretion, deems necessary or desirable; (3) neither the Reporting Entity nor either of such attorneys in fact assumes (i) any liability for the undersigned's responsibility to comply with the requirements of the Exchange Act or (ii) any liability of the undersigned for any failure to comply with suchrequirements; and (4) this Limited Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 13 of the Exchange Act. The undersigned hereby gives and grants each of the foregoing attorneys-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that each such attorney in fact of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney. This Limited Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to each such attorney in fact. IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of this 13th day of October, 2015. For and on behalf of Franklin Templeton Investment Funds /s/Gregory Johnson Director /s/Vijay Advani Director
Exhibit Information

Exhibit A: Joint Filing Agreement Exhibit B: Item 4 Ownership Exhibit C: Item 7 Identification and Classification of Subsidiaries Exhibit A: JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other of the attached statement on Schedule 13G and to all amendments to such statement and that such statement and all amendments to such statement are made on behalf of each of them. IN WITNESS WHEREOF, the undersigned have executed this agreement on the date of the signing of this filing. Franklin Resources, Inc. Charles B. Johnson Rupert H. Johnson, Jr. Franklin Advisers, Inc. By: /s/THOMAS C. MANDIA Assistant Secretary of Franklin Resources, Inc. Attorney in Fact for Charles B. Johnson pursuant to Power of Attorney Attorney in Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney Assistant Secretary of Franklin Advisers, Inc. Acknowledgment pursuant to Rule 13d-1(b)(1)(iii) Franklin Strategic Series on behalf of Franklin Biotechnology Discovery Fund By: /s/ALISON E. BAUR Vice President and Assistant Secretary of Franklin Strategic Series Franklin Templeton Investment Funds on behalf of Franklin Biotechnology Discovery Fund /s/ KIMBERLY D. HARPER Attorney-in-Fact for Franklin Templeton Investment Funds pursuant to Power of Attorney attached to this Schedule 13G Named changed from KIMBERLY H. NOVOTNY. Exhibit B: Item 4 Ownership The securities reported herein are beneficially owned by one or more open or closed end investment companies or other managed accounts that are investment management clients of investment managers that are direct and indirect subsidiaries (each, an "Investment Management Subsidiary" and, collectively, the "Investment Management Subsidiaries") of Franklin Resources Inc. ("FRI"), including the Investment Management Subsidiaries listed in this Item 4. When an investment management contract (including a sub advisory agreement) delegates to an Investment Management Subsidiary investment discretion or voting power over the securities held in the investment advisory accounts that are subject to that agreement, FRI treats the Investment Management Subsidiary as having sole investment discretion or voting authority, as the case may be, unless the agreement specifies otherwise. Accordingly, each Investment Management Subsidiary reports on Schedule 13G that it has sole investment discretion and voting authority over the securities covered by any such investment management agreement, unless otherwise noted in this Item 4. As a result, for purposes of Rule 13d-3 under the Act, the Investment Management Subsidiaries listed in this Item 4 may be deemed to be the beneficial owners of the securities reported in this Schedule 13G. Beneficial ownership by Investment Management Subsidiaries and other FRI affiliates is being reported in conformity with the guidelines articulated by the SEC staff in Release No. 34-39538 (January 12, 1998) (the "1998 Release") relating to organizations, such as FRI, where related entities exercise voting and investment powers over the securities being reported independently from each other. The voting and investment powers held by each of FRI's affiliates whose ownership of securities is disaggregated from that of FRI in accordance with the 1998 Release ("FRI Disaggregated Affiliates") are exercised independently from FRI and from all other Investment Management Subsidiaries (FRI, its affiliates and the Investment Management Subsidiaries other than FRI Disaggregated Affiliates are collectively, "FRI Aggregated Affiliates"). Furthermore, internal policies and procedures of, on the one hand, FRI Disaggregated Affiliates, and, on the other hand, FRI establish informational barriers that prevent the flow among, on the one hand, FRI Disaggregated Affiliates (including preventing the flow between such entities), and, on the other hand, the FRI Aggregated Affiliates of information that relates to the voting and investment powers over the securities owned by their respective investment management clients. Consequently, FRI Disaggregated Affiliates report the securities over which they hold investment and voting power separately from the FRI Aggregated Affiliates for purposes of Section 13 of the Act. Charles B. Johnson and Rupert H. Johnson, Jr. (the "Principal Shareholders") may each own in excess of 10% of the outstanding common stock of FRI and are the principal stockholders of FRI (see FRI's Proxy Statement-Stock Ownership of Certain Beneficial Owners). FRI and the Principal Shareholders may be deemed to be, for purposes of Rule 13d-3 under the Act, the beneficial owners of securities held by persons and entities for whom or for which FRI subsidiaries provide investment management services. The number of shares that may be deemed to be beneficially owned and the percentage of the class of which such shares are a part are reported in Items 9 and 11 of the cover page for FRI. FRI, the Principal Shareholders and each of the Investment Management Subsidiaries disclaim any pecuniary interest in any of such securities. In addition, the filing of this Schedule 13G on behalf of the Principal Shareholders, FRI and the FRI Aggregated Affiliates, as applicable, should not be construed as an admission that any of them is, and each of them disclaims that it is, the beneficial owner, as defined in Rule 13d-3, of any of the securities reported in this Schedule 13G. FRI, the Principal Shareholders, and each of the Investment Management Subsidiaries believe that they are not a "group" within the meaning of Rule 13d-5 under the Act and that they are not otherwise required to attribute to each other the beneficial ownership of the securities held by any of them or by any persons or entities for whom or for which the Investment Management Subsidiaries provide investment management services. EXHIBIT C: Item 7 Identification and Classification of Subsidiaries Franklin Advisers, Inc.: Item 3 Classification: 3(e)

Achieve Life Sciences Inc

NASDAQ:ACHV

ACHV Rankings

ACHV Latest News

ACHV Latest SEC Filings

ACHV Stock Data

130.17M
47.86M
3.65%
32.4%
4.92%
Biotechnology
In Vitro & in Vivo Diagnostic Substances
Link
United States
SEATTLE